This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Intron Biotechnology Co., Ltd. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Yeon Hee Ban: Innovator in Nerve Regeneration
Introduction
Yeon Hee Ban is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in nerve regeneration. With a total of 3 patents, his work focuses on developing innovative solutions for nervous system diseases.
Latest Patents
One of Yeon Hee Ban's latest patents is an FK506 derivative that maintains nerve regeneration activity without immunosuppressive effects. This invention relates to a pharmaceutical composition that can prevent or treat nervous system diseases while minimizing side effects. The composition includes 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506, which promote nerve regeneration and reduce immunosuppressive activity.
Career Highlights
Throughout his career, Yeon Hee Ban has worked with notable companies such as Intron Biotechnology Co., Ltd. and Reyon Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the development of pharmaceutical innovations.
Collaborations
Yeon Hee Ban has collaborated with several professionals in his field, including Yeo Joon Yoon and Ho Jeong Kwon. These collaborations have further enhanced his research and development efforts in nerve regeneration.
Conclusion
Yeon Hee Ban is a dedicated inventor whose work in nerve regeneration has the potential to transform treatments for nervous system diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.